Publications by the researcher in collaboration with Rosa Casais (20)

2024

  1. Inmunidad entrenada, una nueva teoría para un viejo y poderoso concepto: Efectos protectores no-específicos de una vacuna basada en Mycobacterium bovis inactivado en un modelo de sarna en conejo

    Tecnología agroalimentaria: Boletín informativo del SERIDA, Núm. 30, pp. 33-38

  2. Non-specific effects of inactivated Mycobacterium bovis oral and parenteral treatment in a rabbit scabies model

    Veterinary research, Vol. 55, Núm. 1, pp. 41

2023

  1. Efficacy of heat-inactivated Mycobacterium bovis vaccine delivered to European badgers (Meles meles) through edible bait

    Heliyon, Vol. 9, Núm. 9

  2. Summary-data based Mendelian randomization identifies gene expression regulatory polymorphisms associated with bovine paratuberculosis by modulation of the nuclear factor Kappa β (NF-κß)-mediated inflammatory response

    BMC Genomics, Vol. 24, Núm. 1

2022

  1. Evaluation of a droplet digital PCR assay for quantification of Mycobacterium avium subsp. paratuberculosis DNA in whole-blood and fecal samples from MAP-infected Holstein cattle

    Frontiers in Veterinary Science, Vol. 9

  2. Use of ATP-Binding Cassette Subfamily A Member 13 (ABCA13) for Sensitive Detection of Focal Pathological Forms of Subclinical Bovine Paratuberculosis

    Frontiers in Veterinary Science, Vol. 9

2021

  1. Author Correction: Identification of loci associated with susceptibility to bovine paratuberculosis and with the dysregulation of the MECOM, eEF1A2, and U1 spliceosomal RNA expression (Scientific Reports, (2021), 11, 1, (313), 10.1038/s41598-020-79619-x)

    Scientific Reports

  2. Bovine intelectin 2 expression as a biomarker of paratuberculosis disease progression

    Animals, Vol. 11, Núm. 5

  3. Control de la paratuberculosis bovina. Identificación y validación de biomarcadores de detección precoz de la enfermedad

    MG Mundo ganadero, Año 32, Núm. 298, pp. 28-33

  4. Control de la paratuberculosis bovina: nuevos métodos de diagnóstico basados en la detección de biomarcadores bovinos

    Tecnología agroalimentaria: Boletín informativo del SERIDA, Núm. 24, pp. 22-32

  5. Identification of loci associated with susceptibility to bovine paratuberculosis and with the dysregulation of the MECOM, eEF1A2, and U1 spliceosomal RNA expression

    Scientific Reports, Vol. 11, Núm. 1

  6. Spatial and temporal distribution of mycobacterium tuberculosis complex infection in eurasian badger (Meles meles) and cattle in asturias, spain

    Animals, Vol. 11, Núm. 5

2020

  1. Correlations between single nucleotide polymorphisms in bovine CD209, SLC11A1, SP110 and TLR2 genes and estimated breeding values for several traits in Spanish Holstein cattle

    Heliyon, Vol. 6, Núm. 6

  2. Detection of latent forms of Mycobacterium avium subsp. paratuberculosis infection using host biomarker-based ELISAs greatly improves paratuberculosis diagnostic sensitivity

    PLoS ONE, Vol. 15, Núm. 9 September 2020

  3. Local lung immune response to mycobacterium bovis challenge after BCG and M. Bovis heat-inactivated vaccination in European Badger (meles meles)

    Pathogens, Vol. 9, Núm. 6, pp. 1-16

  4. Paratuberculosis bovina. Un posible nuevo objetivo de mejora genética

    Frisona española, Año 40, Núm. 238, pp. 52-54

2018

  1. Clinical course and pathogenicity of variant rabbit haemorrhagic disease virus in experimentally infected adult and kit rabbits: Significance towards control and spread

    Veterinary Microbiology, Vol. 220, pp. 24-32

2017

  1. Lambs are Susceptible to Experimental Challenge with Spanish Goat Encephalitis Virus

    Journal of Comparative Pathology, Vol. 156, Núm. 4, pp. 400-408

  2. Vaccination against Louping Ill Virus Protects Goats from Experimental Challenge with Spanish Goat Encephalitis Virus

    Journal of Comparative Pathology, Vol. 156, Núm. 4, pp. 409-418

2014

  1. Sensitive and specific enzyme-linked immunosorbent assay for detecting serum antibodies against Mycobacterium avium subsp. paratuberculosis in fallow deer

    Clinical and Vaccine Immunology, Vol. 21, Núm. 8, pp. 1077-1085